Skip to content
Psychiatrist.com Logo
  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Advanced Search

Menu

  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Sign in Subscribe

Clinical Topics

View All
  • Addiction
  • ADHD
  • Alzheimer’s Disease
  • Anxiety
  • Bipolar Disorder
  • Depression
  • Movement Disorders
  • Neurology
  • OCD
  • Psychopharmacology
  • PTSD and Trauma
  • Schizophrenia/Schizoaffective Disorders
  • Sleep
  • Tardive Dyskinesia
  • View All

Collections

View All
  • Academic Highlights
  • Auvelity: Information from Industry
  • Banner Alzheimer’s Institute
  • Clinical & Practical Psychopharmacology
  • Early Career Psychiatrists
  • Focus on Childhood and Adolescent Mental Health
  • Focus on Geriatric Psychiatry
  • Focus on Psychotherapy
  • Focus on Suicide
  • Focus on Psychosis
  • Focus on Women’s Mental Health
  • Rounds in the General Hospital
  • UZEDY: Information from Industry
  • View All
Back to top Open menu arrow
Download PDF Reprints
No sections available

The Journal of
Clinical Psychiatry

Free access
Posttraumatic Stress Disorder

Original Research PTSD and Trauma March 15, 2006

Exacerbation of PTSD Symptoms With Use of Duloxetine

Michele L. Deneys; Eileen P. Ahearn

J Clin Psychiatry 2006;67(3):393-394

Article Abstract

Letter to the Editor

Exacerbation of PTSD Symptoms With Use of Duloxetine

 

About the Authors

  • Michele L. Deneys
    View full profile
  • Eileen P. Ahearn
    View full profile
Buy PDF for $40.00

Please sign in or purchase this PDF for $40.00.

Related News Articles

Weekly Mind Reader: New Tool Targets PTSD Treatment Weekly Mind Reader: Younger Vet Face Triple PTSD Risk The Many Faces of PTSD

Sponsored

PsychCase360: Choosing the Right Long-Acting Injectable for Patients With Schizophrenia
Explore two real-world schizophrenia cases with Roueen Rafeyan, MD and Melissa Vitale, PMHNP as they discuss challenges with medication adherence, transitioning to long-acting injectables (LAIs), and personalizing treatment strategies to improve patient outcomes.

Related JCP Articles

Emory Treatment Resistance Interview for PTSD—Short Version Identifying Factors Linked to PTSD Among Younger US Military Veterans Effects of the October 7, 2023, Terrorist Attack on PTSD, Depression, Anxiety, and Suicidal Ideation Across Distinct Exposure Groups

Related PCC Articles

PTSD Management in Primary Care Sequelae of Adverse Childhood Experiences Psychosis-Related PTSD
Cover of The Journal of Clinical Psychiatry, September 2025 issue, featuring article titles on postpartum distress, aripiprazole monohydrate injectables for schizophrenia and bipolar disorder, and other psychiatric topics.

Vol 86 • 2025 • Number 3

Read the Current Issue

Original Research

Treatment Use and Preference in a Diverse Sample of Women With Mood Disorders

Original Research

Klotho and Matrix Metalloproteinase-9 Levels and Their Association with Inhibitory Dyscontrol in Adolescents with First-Episode Major Affective Disorders

Original Research

Niacin-Induced Response in Early Psychosis

Original Research

Early Ketamine Response Reduces Suicidal Events at 3 Months

Letter to the Editor

Suicide Risk among Patients with Bipolar Disorder: Sleep Disruption versus Benzodiazepine Use

Original Research

Effect of Nature Videos on the Burden of Caregivers of Patients with Dementia

View current Issue

Related Articles

PCC
Evolution of Treatment Modalities for PTSD
Original Research

Evolution of Treatment Modalities for PTSD

December 12, 2024

The authors provide a bibliometric analysis of the most-cited articles published from 1990 to 2020 on evidence-based treatment modalities for PTSD to highlight significant developments in its understanding and management.
Mujeeb U. Shad, Mohsan Ali, Muhammad Talha, et al
JCP
PTSD and Risk of Suicide Reattempt
Original Research

PTSD and Risk of Suicide Reattempt

November 25, 2024

After controlling for comorbid psychiatric conditions and other variables, PTSD was associated with suicide reattempt at 6 months (OR= 2.33) and with rehospitalization in psychiatric settings (OR=2.24) and nonpsychiatric...
Alice Demesmaeker, Fabien D’Hondt, Ali Amad, et al
JCP
Hyperbaric Oxygen Therapy for Combat-Associated PTSD
Original Research

Hyperbaric Oxygen Therapy for Combat-Associated PTSD

November 10, 2024

Hyperbaric oxygen therapy demonstrated significant improvements on measures of depression in male veterans with combat-associated PTSD.
Keren Doenyas-Barak, Ilan Kutz, Erez Lang, et al

Watch the New PsychCase360

Explore two real-world schizophrenia cases
Promotional banner for a video titled “Choosing the Right LAI for Patients With Schizophrenia” featuring headshots of Roueen Rafeyan, MD, and Melissa Vitale, PMHNP, with a “Watch Now” button.

Subscribe to read
more articles

Subscribe
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

ELSEWHERE:

  • ABOUT
  • ADVERTISERS
  • MEDIA RELATIONS
  • REPRINTS & PERMISSIONS
  • CONTACT US
  • CUSTOMER SUPPORT

FOLLOW US:

  • X
  • FACEBOOK
  • INSTAGRAM
  • LINKEDIN
  • SIGN IN

  • JOIN THE EMAIL LIST


SUBSCRIBE NOW
An image of the Psychiatrist.com logo mark
  • Privacy Policy
  • Terms of Use
  • Physicians Postgraduate Press, Inc.
  • JCP ISSN: Online 1555-2101, Print 0160-6689
  • PCC ISSN: Online 2155-7780, Print 2155-7772
  • MedFair.com US Patent No. 684794
  • © Copyright 2025 | Physicians Postgraduate Press, Inc. | LifeLong Learning For Clinicians
  • Sitemap